Romain P.
- Country
- France
- Department
- Maladies Infectieuses
Research Overview
- Evaluation of Doravirine, Tenofovir Disoproxil, and Lamivudine in Virologically Controlled HIV-1 Patients with Historical M184V/I Mutation: A Phase II Open-Label Study
- Phase II Pilot Study on Dual Antiretroviral Therapy with Long-Acting Cabotegravir and Lenacapavir in HIV-Infected Patients
- Comparative Study of Doravirine/Lamivudine Versus Dolutegravir/Lamivudine for Maintenance Therapy in HIV Patients with Suppressed Viral Load
Data & Insights
Has run more than one trial at 10 of 41 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in evaluating novel therapeutic approaches for HIV-1 infection, with particular focus on investigating dual and combination antiretroviral therapies. Their research encompasses the study of innovative treatments including doravirine-based combinations and long-acting injectable formulations.
- Antiretroviral combination therapies
- Treatment optimization strategies
- Viral suppression management
The investigator explores maintenance therapy options for patients with controlled HIV infection.
HIV Prevention Research
Their work extends into preventive medicine, particularly investigating pre-exposure prophylaxis (PrEP) strategies. The research focuses on comparing different preventive approaches, including innovative long-acting injectable medications for high-risk populations.
- Injectable PrEP formulations
- Prevention strategies for at-risk groups
- Prophylaxis persistence studies
The investigator evaluates sustained prevention methods to enhance HIV prevention outcomes.
Advanced HIV Therapeutics
The investigator studies cutting-edge therapeutic approaches including broadly neutralizing antibodies (bNAbs) and their potential in HIV treatment. Their research encompasses viral remission strategies and innovative treatment combinations for primary HIV infection.
- Antibody-based therapies
- Treatment protocols for primary infection
- Viral mutation management
Their work includes evaluation of treatment responses in patients with specific viral mutations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.